Latest stories on ADAG
Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138
TipRanks67 · bullishproduct/pr
Adagene Announces NMPA Clearance of Investigational New Drug Application for ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager
Business Insider63 · neutralproduct/pr
Adagene Inc. (ADAG) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
H.C. Wainwright reiterates Adagene stock rating on milestone payments
Investing.com Analyst Ratings56 · neutralanalyst
Adagene Deepens Third Arc Bio Partnership as First SAFEbody-Based CD3 Lead Selected
TipRanks63 · neutralproduct/pr
Adagene initiated with a Buy at Chardan
The Fly61 · neutralanalyst
Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration
TipRanks63 · neutralproduct/pr
Adagene announces $2M milestone payment from Exelixis
The Fly63 · neutralgeneral
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
GlobeNewswire67 · bullishproduct/pr
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
Business Insider67 · bullishproduct/pr
Adagene to Participate in Three Upcoming Investor Conferences
GlobeNewswire55 · neutralgeneral
Adagene ADR Non-GAAP EPS of -$0.20, revenue of $1.62M
Seeking Alpha34 · bearishearnings
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
Business Insider55 · neutralgeneral
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
GlobeNewswire50 · neutralearnings